Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools GIST

GIST

Programs, trials, and reported response and survival for gastrointestinal stromal tumor.

Data as of 11.07.2026

GIST pipeline

Drugs

Every gastrointestinal stromal tumor program in this file, grouped by class. Open a drug for its studies and the sources behind each figure.

ClassNone selected
Route

A route is listed here when at least one program uses it. The full list is on Methods. Unknown means the source did not name a route.

Approved only.

Clear filters

5 of 17 programs shown

KIT/PDGFRA TKI (type II) 1 drug

KIT/PDGFRA type I TKI 1 drug

  • AvapritinibAyvakitBlueprint MedicinesApprovedoral2 studiesKIT/PDGFRA type I TKI

multi-kinase TKI 1 drug

multi-kinase TKI (type II) 1 drug

switch-control KIT/PDGFRA TKI 1 drug

  • RipretinibQinlockDeciphera PharmaceuticalsApprovedoral3 studiesswitch-control KIT/PDGFRA TKI